SARS-CoV-2-IN-43 (Compound 8h) is a potent small-molecule inhibitor that effectively blocks SARS-CoV-2 replication. It demonstrates significant antiviral activity in vitro and is a valuable tool for research in virology and antiviral drug discovery.